| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 166,007 | 165,278 | 149,797 | 152,106 | | Cost of Revenue | 115,760 | 116,118 | 106,601 | 107,825 | | | Gross Profit | 50,247 | 49,160 | 43,196 | 44,281 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 33,818 | 34,631 | 34,449 | 34,527 | | Non Recurring | 963 | 3,756 | 891 | 2,146 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 15,466 | 10,773 | 7,856 | 7,608 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (76) | 543 | 368 | 466 | | Earnings Before Interest And Taxes | 15,390 | 11,316 | 8,224 | 8,074 | | Interest Expense | 2,471 | 2,401 | 2,373 | 2,880 | | Income Before Tax | 12,919 | 8,915 | 5,851 | 5,194 | | Income Tax Expense | 4,095 | 2,906 | 1,800 | 1,772 | | Minority Interest | (579) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,245 | 6,009 | 4,051 | 3,422 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,245 | 6,009 | 4,051 | 3,422 | | Preferred Stock And Other Adjustments | 389 | (185) | (204) |
-
| | | Net Income Applicable To Common Shares | $8,634 | $5,824 | $3,847 | $3,422 |
|
0.26% Nasdaq 0.00%
Income Statement
